ADULT AND PEDIATRIC HEMOCONCENTRATORS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Adult and Pediatric Hemoconcentrators Market Forecast - 2026 to 2033

Adult and pediatric hemoconcentrators market is estimated to be valued at USD 14.3 Mn in 2026 and is expected to reach USD 17.7 Mn in 2033, exhibiting a compound annual growth rate (CAGR) of 3.3% from 2026 to 2033.

Key Takeaways

• Based on Product Type, the Adult Hemoconcentrator segment is expected to hold 72.8% share of the market in 2026.
• Based on End User, the Hospitals segment is expected to lead the market with 67.4% share in 2026.
• Based on Region, North America is set to lead the adult and pediatric hemoconcentrators market with 39.5% share in 2026. While, Asia Pacific is anticipated to be the fastest growing region.

Market Overview

A hemoconcentrator is a device used for removal of fluid during cardio bypass surgery. Hemoconcentrators are introduced in extracorpeal circuit where it controls hemodilution, maintains hematocrit levels, and reduces the need for additional blood products during and after surgery. Hemoconcentrators are widely used during cardiac bypass surgery and has become the ideal method for controlling hemodilution during cardiopulmonary surgery by surgeons and perfusionists.

Current Events and Its Impacts on the Adult and Pediatric Hemoconcentrators Market

Reimbursement Policy

1. United States

• Hemoconcentrators are typically covered under Medicare and private insurance as part of cardiopulmonary bypass or extracorporeal circulation procedures.
• Reimbursement is not device-specific; instead, costs are included in Diagnosis-Related Group (DRG) payments for cardiac or trauma surgeries.
• Hospitals often negotiate with payers to ensure coverage, but standalone reimbursement for hemoconcentrators is rare.

2. Europe

• Coverage is provided under national health systems (e.g., NHS in the UK, statutory insurance in Germany).
• Similar to the U.S., reimbursement is bundled into surgical procedure costs rather than itemized for hemoconcentrators.
• Strict regulatory and cost-containment policies limit pricing flexibility, which impacts adult and pediatric hemoconcentrators market in Europe.

Regulatory Requirements

Segmental Insights 

Adult and Pediatric Hemoconcentrators Market Insights, By Product Type: Adult hemoconcentrators dominance is driven by the high volume of adult cardiac surgeries

In terms of product type, the adult hemoconcentrator segment is expected to hold 72.8% share of the market in 2026, due to the significantly higher prevalence of cardiovascular diseases among adults and the aging global population. With more open-heart surgeries performed on adults, demand for reliable extracorporeal circulation devices rises. Their widespread adoption ensures adult hemoconcentrators remain the leading product type segment in 2026.

For instance, in August 2025, LivaNova launched its Essenz Perfusion System in China, enhancing extracorporeal circulation technology for cardiac surgery. The system integrates advanced monitoring, data management, and patient safety features, supporting clinicians in optimizing outcomes. This expansion strengthens LivaNova’s presence in Asia’s growing cardiovascular market and advances modern perfusion practices for adult patients.

Adult and Pediatric Hemoconcentrators Market Insights, By End User: Hospitals lead as they perform most complex cardiovascular procedures requiring hemoconcentrators

In terms of end user, the hospitals segment is expected to lead the market with 67.4% share in 2026, because they perform the majority of complex cardiac surgeries requiring hemoconcentrators. Equipped with advanced infrastructure, intensive care units, and specialized perfusion teams, hospitals handle large patient volumes. Their central role in cardiovascular treatment ensures hospitals maintain dominance as the primary end-user segment in 2026.

Regional Insights 

North America Adult and Pediatric Hemoconcentrators Market Analysis & Trends

North America is expected to dominate the adult and pediatric hemoconcetrators market with 39.50% share in 2026, due to advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and an aging population requiring frequent cardiac surgeries. Strong presence of leading medical device manufacturers and specialized hospitals further drives adoption, ensuring regional market dominance.

For instance, in January 2026, Tomorrow Health’s Horizon Suite streamlines ordering, routing, and fulfillment of durable medical equipment for home-based care. By strengthening healthcare logistics infrastructure, it reduces provider burden and accelerates patient access. This modernization also indirectly benefits the Adult and Pediatric Hemoconcentrators Market through improved supply chain efficiency and coordinated delivery systems.

Asia Pacific Adult and Pediatric Hemoconcentrators Market Analysis & Trends

Asia Pacific is expected to exhibit the fastest growth of the market, driven by rising cardiovascular surgeries, expanding pediatric care infrastructure, and growing healthcare investments. Increasing prevalence of heart diseases, adoption of advanced surgical devices, and government initiatives to modernize hospitals further fuel market growth across the region.

For instance, in January 2026, Novo Holdings’ investment in Surya Hospitals expands pediatric and maternal healthcare infrastructure in India. Enhanced hospital capacity, neonatal services, and advanced technology indirectly benefit the Adult and Pediatric Hemoconcentrators Market by strengthening surgical support systems, improving extracorporeal circulation management, and ensuring better access to critical devices during complex procedures.

Adult and Pediatric Hemoconcentrators Market Outlook Country-Wise

The U.S. Adult and Pediatric Hemoconcentrators Market Trends

The United States dominates the Adult and Pediatric Hemoconcentrators Market, driven by high cardiac surgery volumes and widespread adoption of extracorporeal circulation devices. Leading manufacturers, advanced hospitals, and specialized surgical centers ensure strong demand. Robust infrastructure, skilled professionals, and continuous innovation further reinforce its position as the largest global market.

For instance, in January 2025, Inspira Technologies is preparing its first life support systems for deployment at a leading U.S. hospital. These extracorporeal circulation devices provide advanced blood oxygenation and circulation support, offering critical care for patients with severe respiratory or cardiac failure. The launch marks a significant step in expanding lifesaving technologies.

Germany Adult and Pediatric Hemoconcentrators Market Trends

In 2026, Germany’s demand for Adult and Pediatric Hemoconcentrators is driven by high cardiac surgery volumes, advanced extracorporeal circulation practices, and strong hospital infrastructure. Rising cases of congenital heart disease, aging population needs, and adoption of innovative perfusion technologies further strengthen Germany’s position as a leading European market.

For instance, in September 2025, The first clinical experience with CBM LifeMotion at Universitätsmedizin Frankfurt highlights Germany’s leadership in advanced extracorporeal circulation practices. The system optimizes perfusion and blood management, enhancing patient safety and efficiency. This milestone demonstrates innovation in critical care, positioning Germany as a key region for extracorporeal technology adoption and growth.

Market Report Scope 

Adult and Pediatric Hemoconcentrators Market Driver

Rising Cardiovascular and Cardiac Surgery Cases

The global burden of cardiovascular diseases continues to rise, leading to an increase in surgical interventions such as bypass operations and valve replacements. Hemoconcentrators play a critical role in extracorporeal circulation during these procedures, ensuring efficient blood management and reducing complications. With the aging population in regions like North America and Europe, the reliance on these devices is expected to grow steadily. This trend significantly boosts the adult and pediatric hemoconcentrators market share, highlighting their importance in advanced cardiac care.

Trauma and Emergency Surgeries

Hemoconcentrators are indispensable in trauma surgery, liver transplantation, and emergency medicine, where rapid blood volume management is crucial to patient survival. By reducing the need for transfusions, these devices enhance surgical outcomes and minimize risks. The rising incidence of accidents, trauma cases, and complex emergency procedures worldwide is fueling adoption across hospitals and surgical centers. This growing reliance underscores the increasing adult and pediatric hemoconcentrators market demand, as healthcare providers seek reliable solutions for critical care and emergency interventions.

Analyst Opinion (Expert Opinion)

The adult and pediatric hemoconcentrators market is experiencing steady demand driven by expanding clinical use in cardiovascular and renal care settings. Hemoconcentrators are critical in extracorporeal procedures, where they remove excess fluid from blood to maintain optimal hematocrit levels, an essential function during cardiac surgery, dialysis, plasmapheresis, and other intensive interventions. Rising prevalence of cardiovascular diseases across age groups and increased utilization of advanced surgical techniques underpin the need for these devices.

Market segmentation shows a clear distinction between adult and pediatric applications, with adult devices historically representing the larger volume due to higher procedural frequencies in adult cardiac care. Pediatric hemoconcentrators, while smaller in unit demand, are gaining traction as pediatric cardiac surgery access broadens in emerging healthcare systems. Clinical adoption patterns indicate that hospitals remain the dominant end-use setting, with specialty surgical centers also contributing to increased unit deployment where advanced extracorporeal support is required.

Technological innovation plays an influential role. Ultrafiltration remains a leading filtration method, favored for its efficiency in fluid balance and blood conservation. Polymer-based hemoconcentrators hold preference for their durability, biocompatibility, and performance consistency, which enhances patient outcomes and procedural reliability.

Geographically, North America has established a strong presence due to advanced healthcare infrastructure and broad procedural volumes. Asia-Pacific is emerging rapidly, supported by investments in cardiac care facilities and expanding surgical capacities in markets such as China and India.

Market Segmentation

• By Product Type
  • Adult Hemoconcentrators
  • Pediatric Hemoconcentrators
• By End User
  • Hospital
  • Ambulatory Surgical Centers
  • Others
• By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
• Adult and Pediatric Hemoconcentrators Market Companies
  • Medivators Inc.
  • Terumo Corporation
  • LivaNova, PLC
  • Maquet (a Getinge Group company)
  • Medica S.p.A

Sources

Primary Research Interviews

• Cardiothoracic Surgeons
• Cardiac Perfusionists (Adult & Pediatric)
• Pediatric Cardiac Surgery Specialists
• Clinical Engineers – Cardiopulmonary Bypass (CPB) Systems
• Hemoconcentrator & Blood Management Device Manufacturers
• Hospital Procurement & Biomedical Engineering Heads
• Others

Databases

• Bloomberg Terminal
• Thomson Reuters Eikon
• Others

Magazines

• Perfusion.com
• Cardiovascular Business
• Medical Device Network
• Healthcare Purchasing News
• European Medical Device Technology
• Others

Journals

• The Journal of Extra-Corporeal Technology
• The Journal of Thoracic and Cardiovascular Surgery
• Perfusion Journal (SAGE)
• Pediatric Cardiology
• Annals of Thoracic Surgery
• Artificial Organs Journal
• Others

Newspapers

• Financial Times
• The Wall Street Journal
• Reuters
• Bloomberg News
• STAT News (Healthcare)
• Others

Associations

• American Society of ExtraCorporeal Technology (AmSECT)
• European Board of Cardiovascular Perfusion (EBCP)
• Society of Thoracic Surgeons (STS)
• European Association for Cardio-Thoracic Surgery (EACTS)
• American Heart Association (AHA)
• World Federation of Pediatric Intensive & Critical Care Societies (WFPICCS)
• Others

Public Domain Sources

• U.S. Food and Drug Administration (FDA) – Medical Device Databases
• U.S. Centers for Disease Control and Prevention (CDC)
• National Institutes of Health (NIH)
• World Health Organization (WHO)
• OECD Health Statistics
•  ClinicalTrials.gov
• European Medicines Agency (EMA)
• Others

Proprietary Elements

• CMI Data Analytics Tool
• Proprietary CMI Existing Repository of Information for the Last 8 Years